Drug Cos. Say Noerr Doctrine Bars FTC's Pay-For-Delay Suit
Par Pharmaceutical Cos. Inc. and Paddock Laboratories Inc. once again moved to dismiss the Federal Trade Commission's pay-for-delay case against them Wednesday, arguing they were protected from the government's antitrust claims...To view the full article, register now.
Already a subscriber? Click here to view full article